Use of angiotensin II agonists
AssigneeVicore Pharma AB
InventorsUlrike Steckelings, Thomas Unger
Life of this patent
Estimating the term…
Abstract
There is provided a compound of formula I, wherein Y1, Y2, Y3, Y4, Z1, Z2, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, for use in the treatment of spinal cord injury.
Claims18
A method of treating spinal cord injury, comprising administering a compound which is an AT2 receptor agonist that binds selectively to the AT2 receptor, or a pharmaceutically acceptable salt thereof, to a patient in need of such therapy.
A method of treating spinal cord injury, comprising administering a compound which is capable of stimulating AT2 receptors, or a pharmaceutically acceptable salt thereof, to a patient in need of such therapy.
A method of treating a spinal cord injury comprising administering a pharmaceutical formulation including a compound which is an AT2 receptor agonist that binds selectively to the AT2 receptor, or a pharmaceutically acceptable salt thereof, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier to a patient in need of such therapy.
Dependencies are inferred from the claim text.